Internalised Stigma in Hidradenitis Suppurativa; A multicentre cross-sectional study


Creative Commons License

Gülbaşaran F.

31st EADV congress, Milan, İtalya, 7 - 10 Eylül 2022

  • Yayın Türü: Bildiri / Yayınlanmadı
  • Basıldığı Şehir: Milan
  • Basıldığı Ülke: İtalya
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

In total, 731 patients with HS (281 females, 450 males) were included in the study. The mean age of the patients was

33.43±11.54 (12-73) years (women, 29.56±9.99; men, 35.85±11.78) (p<0.001). The mean age of disease onset was

24.92±10.14 (7-69) years. The onset of the disease was earlier in women (21.94±8.69) than in men (26.78±10.53) (p<0.001).

The sociodemographic features of patients participating in the study are presented in Table 1. The most common symptoms

were purulent discharge (79.9%), pain (76.6%) and abscess (75.5%). When we examined the involvement sites, the axillar

area (80.4%) was the most frequently involved site, followed by the inguinal area (61.8%) and buttocks (38.4%) Most of the

patients were in HSt-2 and PGA-moderate group (Table 2).

The mean ISS value was 57.50±16.90 and the internal consistency coefficient for the whole scale was 0.93. The mean values

of other scales were 69.25±26.79 for Skindex-16, 13.88±8.98 for DLQI, 15.52±13.85 for BDI-II and 5.04±2.83 for VAS-pain

score. A statistically significant correlation was found between the mean values of ISS and all disease activity scores (HSt,

PGA), quality of life measures (Skindex-16, DLQI), psychiatric evaluation with BDI-II, and VAS-pain scores. Mean ISS values

were significantly higher in patients with the active involvement of the pubic area (p<0.001), vulva/scrotum (p=0.003),

perianal area (p<0.001) and buttocks (p<0.001).


According to multivariate analysis; body mass index (BMI) being >30, family history in first- and second-degree relatives, low-

income level, low educational level, involvement of vulva/scrotum, being actively treated were found to be significant and


independent factors for internalized stigma (Table 3).